missing translation for 'onlineSavingsMsg'
Läs mer
  1. Home
  2. Products
  3. Biokemiska reagenser
  4. Peptider
  5. 18040874

R&D Systems™ FIH-1/HIF-1AN Antibody Blocking Peptide

Produktkod. 18040874 Handla allt Bio Techne Produkter
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
0,05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet
18040874 0,05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 18040874 Leverantör R&D Systems™ Leverantörsnummer NB100428PEP
 Begränsad artikel
Beräknad leverans: 20-11-2026
Lägg i varukorgen
Lägg i varukorgen

missing translation for 'validMainframeMsg'

Denna artikel kan inte returneras. Se returpolicy

Description

A Novus product, part of R&D Systems.

A peptide to HIF1AN.
TRUSTED_SUSTAINABILITY

Specifications

Gen-ID (Entrez) 55662
Art Human
Produktlinje Novus
Innehåll och lagring Store at -80 C. Avoid freeze-thaw cycles.
Formulering Peptide dissolved in dH2O. Contains no BSA.
För användning med (applikation) This Peptide is Useful as a Blocking Peptide for NB 100-428. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias DKFZp762F1811, EC 1.14.11.16, factor inhibiting HIF1, Factor inhibiting HIF-1, FIH1FIH-1, FLJ20615, FLJ22027, hypoxia inducible factor 1, alpha subunit inhibitor, hypoxia-inducible factor 1-alpha inhibitor, Hypoxia-inducible factor asparagine hydroxylase, peptide-aspartate beta-dioxygenase
Gensymbol HIF1AN
Produkttyp FIH-1/HIF-1AN
Kvantitet 0,05 mg
Regulatorisk status RUO
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.